Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
No metformin recalls affect U.S. market at the moment
Read More »FDA Testing Levels of Carcinogen in Diabetes Drug Metformin
T1DM May Up Progression of CAC During Menopausal Transition
Findings seen for progression of coronary artery calcium independent of other cardiovascular risk factors
Read More »Prediabetes Prevalent in U.S. Adolescents, Young Adults
Prevalence of prediabetes 18.0 and 24.0 percent among adolescents and young adults, respectively
Read More »Child Consumption of Sugary Drinks Down From 2003 to 2014
Decline seen across income levels, including SNAP participants
Read More »November 2019 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.U.S. Life …
Read More »Alarm Settings of CGM Systems Impact Glucose Control in T1DM
Adjusting glucose thresholds for alarms linked to less time spent in hypoglycemia, hyperglycemia
Read More »Changes in Metabolic Syndrome Status Linked to MACE Risk
Risk for MACE decreased with recovery from metabolic syndrome, while risk up with MetS development
Read More »Risk for Skin Infections, Diabetes Increase With Statin Use
Study shows mechanism of statins can induce onset of diabetes
Read More »Obesity Prevalence Decreased Modestly for Children in WIC
Significant decreases seen for children aged 2 to 4 years enrolled in WIC state, territory agencies
Read More »Prenatal Antidepressant Use May Up Risk for Gestational Diabetes
Venlafaxine, amitriptyline use during pregnancy associated with increased risk for gestational diabetes
Read More »